RONC-08. Validation of Online Calculator for Estimating Severe Hearing Loss Risk Among Patients with Medulloblastoma After Receiving Photon Radiation and Cisplatin Chemotherapy

BACKGROUND: Children with medulloblastoma are at risk of hearing loss (HL) following cranial radiotherapy and platinum-based chemotherapy. Keilty et al. 2021. J Clin Oncol. (PMID: 34570616) recently published a computer-based HL risk calculator based on children with central nervous system tumors tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Arja, Mohammad, Brown, Austin, Lupo, Philip, Chintagumpala, Murali, Paulino, Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165146/
http://dx.doi.org/10.1093/neuonc/noac079.662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165146/
http://dx.doi.org/10.1093/neuonc/noac079.662

Ejemplares similares